We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$10.7B
1-Year Est. Return
67.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+67.78%
3 Year Est. Return
+183.84%
5 Year Est. Return
+266.8%
10 Year Est. Return
+1,486.88%
AUM
$13.7B
AUM Growth
+$435M
(+3.3%)
Cap. Flow
-$546M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
15.96%
Holding
301
New
25
Increased
112
Reduced
147
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$69.3M |
| 2 |
SGFY
Signify Health, Inc.
SGFY
|
+$62.1M |
| 3 |
Natera
NTRA
|
+$56.9M |
| 4 |
Leslie's
LESL
|
+$53.5M |
| 5 |
VMEO
Vimeo
VMEO
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$207M |
| 2 |
Magnite
MGNI
|
+$140M |
| 3 |
Caesars Entertainment
CZR
|
+$89.3M |
| 4 |
PPLI
People Inc
PPLI
|
+$84.5M |
| 5 |
Vulcan Materials
VMC
|
+$59.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.46% |
| 2 | Consumer Discretionary | 19.17% |
| 3 | Healthcare | 18.19% |
| 4 | Industrials | 15.16% |
| 5 | Financials | 12.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Amphastar Pharmaceuticals
AMPH
$1.01B
| $3.73M | 0.03% |
+184,979
| New | +$3.49M |
|
|
TVRD
277
Tvardi Therapeutics
TVRD
$24.9M
| $3.58M | 0.03% |
6,975
-911
| -12% | -$577K |
|
278
Nektar Therapeutics
NKTR
$2.34B
| $2.01M | 0.01% |
7,791
-21,937
| -74% | -$6.07M |
|
|
NSTG
279
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.6M | 0.01% |
24,772
-159,956
| -87% | -$10.2M |
|
280
Revolution Medicines
RVMD
$44B
| $694K | 0.01% |
21,853
-649
| -3% | -$22.7K |
|
281
Teradyne
TER
$51.5B
| $411K | ﹤0.01% |
3,069
-91
| -3% | -$11.6K |
|
282
Five Below
FIVE
$13.7B
| $410K | ﹤0.01% |
2,120
-62
| -3% | -$11.8K |
|
283
Paylocity
PCTY
$7.52B
| $307K | ﹤0.01% |
1,609
-49
| -3% | -$8.82K |
|
284
Insmed
INSM
$27.4B
| $215K | ﹤0.01% |
7,563
-113,846
| -94% | -$3.38M |
|
285
ADC Therapeutics
ADCT
$137M
| – | – |
-78,137
| Closed | -$1.91M |
|
286
Boot Barn
BOOT
$4.37B
| – | – |
-126,815
| Closed | -$7.9M |
|
287
Century Communities
CCS
$1.72B
| – | – |
-88,637
| Closed | -$5.35M |
|
288
Cousins Properties
CUZ
$4.6B
| – | – |
-201,358
| Closed | -$7.12M |
|
289
Darling Ingredients
DAR
$10.3B
| – | – |
-194,383
| Closed | -$14.3M |
|
290
Denali Therapeutics
DNLI
$3.37B
| – | – |
-7,742
| Closed | -$442K |
|
291
Golar LNG
GLNG
$5.25B
| – | – |
-174,767
| Closed | -$1.79M |
|
292
James River Group Holdings
JRVR
$183M
| – | – |
-846,662
| Closed | -$38.6M |
|
|
293
Magnite
MGNI
$3.41B
| – | – |
-3,373,124
| Closed | -$140M |
|
294
MGP Ingredients
MGPI
$316M
| – | – |
-96,661
| Closed | -$5.72M |
|
295
MYR Group
MYRG
$4.23B
| – | – |
-191,274
| Closed | -$13.7M |
|
296
PRA Group
PRAA
$713M
| – | – |
-200,980
| Closed | -$7.45M |
|
|
297
Vulcan Materials
VMC
$32.7B
| – | – |
-352,873
| Closed | -$59.5M |
|
|
NUVA
298
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-407,544
| Closed | -$26.7M |
|
|
CSII
299
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-193,708
| Closed | -$7.43M |
|
|
PLAN
300
DELISTED
Anaplan, Inc.
PLAN
| – | – |
-63,906
| Closed | -$3.44M |
|
Similar funds
VAS
SIM
FMI
HL
RCMF
DPIM
CA
SCM
Frontier Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Frontier Capital Management held 301 positions worth $13.7B, up 3.3% from $13.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Frontier Capital Management withdrew a net $546M in Q2 2021, closing 17 positions and reducing 147 holdings. Its most notable exit was Magnite, an estimated $140M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Signify Health, Inc. worth $68.7M.
- Frontier Capital Management's largest Q2 2021 buy was Signify Health, Inc.: 2,258,629 shares worth $68.7M.
- Frontier Capital Management added most to NovoCure in Q2 2021, an estimated $69.3M increase.
- Frontier Capital Management's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $207M.
- Frontier Capital Management fully exited Magnite in Q2 2021, selling an estimated $140M.
- Frontier Capital Management's ten largest holdings make up 16% of its $13.7B portfolio in Q2 2021.
- Frontier Capital Management opened 25 new positions and closed 17 in Q2 2021.
- Frontier Capital Management's portfolio value rose 3.3% quarter-over-quarter to $13.7B.
Based on Frontier Capital Management's 13F filing for Q2 2021, filed 9 Aug 2021.